Review: taking Coumadin and Hydroxyzine pamoate together


Summary

Drug interactions are reported among people who take Coumadin and Hydroxyzine pamoate together. This review analyzes the effectiveness and drug interactions between Coumadin and Hydroxyzine pamoate. It is created by eHealthMe based on reports of 92 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Hydroxyzine pamoate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 82,667 users)

Hydroxyzine Pamoate

Hydroxyzine pamoate has active ingredients of hydroxyzine pamoate. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine pamoate 1,194 users)

On Aug, 26, 2016

92 people who take Coumadin, Hydroxyzine Pamoate are studied.


Number of reports submitted per year:

Coumadin and Hydroxyzine pamoate drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 2 people)
Hydroxyzine Pamoate:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Hydroxyzine Pamoate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • blood pressure decreased
  • bradycardia
  • cardio-respiratory arrest
  • convulsion
  • epistaxis
  • international normalised ratio increased
  • loss of consciousness
  • mouth haemorrhage
  • oxygen saturation decreased
1 - 6 months:
  • granulocytopenia
not specified:
  • thrombocytopenia
  • anxiety
  • asthenia
  • cardiac failure congestive
  • dyspnoea
  • dehydration
  • diarrhoea
  • blood bilirubin increased
  • death
  • haemorrhage

Most common drug interactions by gender *:

female:
  • anxiety
  • musculoskeletal pain
  • atrial fibrillation
  • diabetes mellitus inadequate control
  • hypokalaemia
  • cardio-respiratory arrest
  • asthenia
  • cardiac failure congestive
  • dehydration
  • depressed mood
male:
  • thrombocytopenia
  • international normalised ratio increased
  • diarrhoea
  • constipation
  • blood bilirubin increased
  • death
  • dyspnoea
  • deep vein thrombosis
  • anxiety
  • asthenia

Most common drug interactions by age *:

20-29:
  • death
30-39:
  • granulocytopenia
40-49:
  • constipation
  • deep vein thrombosis
  • haemoglobin decreased
  • neutropenia
  • pain in extremity
  • thrombocytopenia
  • thrombosis
  • urinary tract infection
  • fatigue
  • fall
50-59:
  • fall
  • feeling cold
  • hyperhidrosis
  • muscle strain
  • musculoskeletal chest pain
  • patella fracture
  • pleurisy
  • tremor
  • cerebral infarction
  • dehydration
60+:
  • cardiac failure congestive
  • thrombocytopenia
  • anxiety
  • asthenia
  • dehydration
  • international normalised ratio increased
  • diarrhoea
  • cardio-respiratory arrest
  • anaemia
  • blood bilirubin increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Hydroxyzine pamoate?

Can you answer these questions?

More questions for: Coumadin, Hydroxyzine pamoate

You may be interested in these reviews

More reviews for: Coumadin, Hydroxyzine pamoate

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Hydroxyzine pamoate (hydroxyzine pamoate) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.